Provide an understanding of where we are in terms of surgical care today
ACS Committee on Trauma Response
Define the term “Aerosol Generating Procedure”
Explain how surgical care may evolve in the next weeks or months
Discuss the latest recommendations of the ACS and their response on COVID-19
Justin Koenig, DO, FACOS, has dedicated his life to serving his country and his patients. The U.S. Air Force Major helped lead surgical teams at home and abroad in his years of military service. He was even deployed to North Africa to help establish trauma care services in developing regions.
While stationed at the U.S. Air Force Academy in Colorado, the Auburn, Ind., native and his family decided to return to the Midwest so he could practice medicine in a more traditional hospital setting. Dr. Koenig wanted to be a part of the Beacon team because of our commitment to improving the lives of our patients.
“As a trauma surgeon, I usually meet people on their worst day imaginable and I make my best effort to heal them,” Dr. Koenig said. “I want to be your ally. It’s my goal to make patients as informed about their care as possible. And I work with each patient to improve his or her overall well-being and ensure they are an integral part of their own healing process.”
Accreditation Statement: The Beacon Health System is accredited by the Indiana State Medical Association to provide continuing medical education for physicians.
Designation Statement: Beacon Health System designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure: Physician(s) and all planners associated with this activity do not have any potential conflict of interest.
Disclosure Statement: As a CME provider accredited by the Indiana State Medical Association, Beacon Health System must ensure balance, independence, objectivity, and scientific rigor in all sponsored educational programs. All faculty participating in these programs must complete a disclosure statement indicating any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufactures, or other corporations whose products or services are related to the subject matter of the presentation topic.
Commercial Support: No commercial support was used in planning or implementation of the CME activity.
On Demand Details: Recordings are available for credit until 4/1/2021
Questions may be directed to Jenai White at 574.647.7691 or firstname.lastname@example.org